VHB Life Sciences Limited manufactures Busulphan Tablets. VHB Life Sciences Limited has WHO GMP certified facility as well as INVIMA approved facility. Busulphan Tablets are available in packing of ten blisters of ten tablets. It is indicated in treatment of diseases such as chronic myelogenous leukemia, Bone marrow/stem cell transplantation for refractory leukemia, lymphoma. It is used in combination with cyclophosphamide as conditioning regimen prior to allogeneic stem cell transplantation for CML. Busulphan Tablets is an alkylating agent and bears the brand name Myran.
